ibuprofen and fluticasone

ibuprofen has been researched along with fluticasone in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Oermann, CM	1
Ek, A; Larsson, K; Palmberg, L; Strandberg, K	1

Reviews

1 review(s) available for ibuprofen and fluticasone

Article	Year
Anti-inflammatory approaches to the treatment of cystic fibrosis lung disease: past, present and future. Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:7 Topics: alpha 1-Antitrypsin; Androstadienes; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Clinical Trials as Topic; Cystic Fibrosis; Fluticasone; Humans; Ibuprofen; Macrolides; Piroxicam; Prednisone; Proteinase Inhibitory Proteins, Secretory; Proteins; Serine Proteinase Inhibitors	2001

Article

Year

Anti-inflammatory approaches to the treatment of cystic fibrosis lung disease: past, present and future.

Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:7

Topics: alpha 1-Antitrypsin; Androstadienes; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Clinical Trials as Topic; Cystic Fibrosis; Fluticasone; Humans; Ibuprofen; Macrolides; Piroxicam; Prednisone; Proteinase Inhibitory Proteins, Secretory; Proteins; Serine Proteinase Inhibitors

2001

Trials

1 trial(s) available for ibuprofen and fluticasone

Article	Year
Fluticasone and ibuprofen do not add to the effect of salmeterol on organic dust-induced airway inflammation and bronchial hyper-responsiveness. Journal of internal medicine, 2008, Volume: 264, Issue:1 Topics: Adrenergic beta-Agonists; Adult; Agricultural Workers' Diseases; Albuterol; Androstadienes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchial Provocation Tests; Bronchodilator Agents; Double-Blind Method; Drug Interactions; Dust; Female; Fluticasone; Forced Expiratory Volume; Humans; Ibuprofen; Male; Methacholine Chloride; Middle Aged; Occupational Exposure; Retrospective Studies; Salmeterol Xinafoate; Swine; Vital Capacity	2008

Article

Year

Fluticasone and ibuprofen do not add to the effect of salmeterol on organic dust-induced airway inflammation and bronchial hyper-responsiveness.

Journal of internal medicine, 2008, Volume: 264, Issue:1

Topics: Adrenergic beta-Agonists; Adult; Agricultural Workers' Diseases; Albuterol; Androstadienes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchial Provocation Tests; Bronchodilator Agents; Double-Blind Method; Drug Interactions; Dust; Female; Fluticasone; Forced Expiratory Volume; Humans; Ibuprofen; Male; Methacholine Chloride; Middle Aged; Occupational Exposure; Retrospective Studies; Salmeterol Xinafoate; Swine; Vital Capacity

2008

Other Studies

1 other study(ies) available for ibuprofen and fluticasone

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004